Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-06-009713
Filing Date
2006-05-02
Accepted
2006-05-02 14:20:43
Documents
1
Period of Report
2006-04-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3734
  Complete submission text file 0001179110-06-009713.txt   5680
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
NEORX CORP (Issuer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 820 THIRD ST SW ROCHESTER MN 55902
Business Address C/O MAY FOUNDATION DVLPMNT DPT SIABENS 9 200 FIRST ST SW ROCHESTER MN 55902 5072828821
DICKSON E ROLLAND (Reporting) CIK: 0001061902 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16614 | Film No.: 06798798